Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript
Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript March 25, 2024 Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41.

